Elevated amylase in plasma represents an adverse prognostic marker in patients with metastatic pancreatic cancer
Asamer, Eva, Szkandera, Joanna, Gibiser, Paul, Lembeck, Anna Lena, Stojakovic, Tatjana, Kornprat, Peter, Lackner, Caroline, Winder, Thomas, Schlick, Konstantin, Stöger, Herbert, Gerger, Armin, PichlerJournal:
Wiener klinische Wochenschrift
DOI:
10.1007/s00508-018-1383-3
Date:
August, 2018
File:
PDF, 425 KB
2018